Researcher Next
Create account
← Back to directory

Rafael Rosell

Researcher Next ID · RN-003016

Researcher · Medicine

Instituto Oncológico Dr. Rosell

Barcelona, Spain

Sign in to saveSign in to claim
Not currently recruitingFunding unknown
Works count
1,002
Citation count
47,499
H-index
95
i10-index
428

Research interests

Medicine
Biochemistry, Genetics and Molecular Biology
Lung Cancer Treatments and Mutations
Lung Cancer Research Studies
Cancer Genomics and Diagnostics
Lung Cancer Diagnosis and Treatment
Cancer Immunotherapy and Biomarkers

Publications

  • Alectinib versus Crizotinib in Untreated ALK -Positive Non–Small-Cell Lung Cancer

    New England Journal of Medicine · 2017 · https://doi.org/10.1056/nejmoa1704795

  • Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group

    Journal of Clinical Oncology · 2008 · https://doi.org/10.1200/jco.2007.13.9030

  • Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB–IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial

    The Lancet Oncology · 2006 · https://doi.org/10.1016/s1470-2045(06)70804-x

  • Gefitinib in Combination With Gemcitabine and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 1

    Journal of Clinical Oncology · 2004 · https://doi.org/10.1200/jco.2004.08.001

  • Gefitinib in Combination With Paclitaxel and Carboplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 2

    Journal of Clinical Oncology · 2004 · https://doi.org/10.1200/jco.2004.07.215

Current projects

    No projects listed.